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Abstract
Traumatic Brain Injury (TBI) often leads to the development of epilepsy, especially with the
occurrence of stressful events. Stressors increase the levels of corticotropin-releasing factor
(CRF) in the amygdala, which can be damaged by the secondary effects of TBI. It is
hypothesized that the activity of CRF receptor type 1 (CRFR1) in the amygdala is altered postTBI and supports the generation of epileptiform waves, namely high-frequency oscillations
(HFOs). Sprague-Dawley rats were given a moderate TBI and in vivo recordings of the amygdala
were taken during the administration of an acute tail pinch stressor. The stressor increased
broadband activity which included the occurrence of HFOs. Moreover, HFO amplitudes were
found to be coupled to the phase of a simultaneous theta wave (4 – 8Hz). Furthermore,
application of a CRFR1 antagonist disrupted the generation of HFOs and their phase-amplitude
coupling with theta, and these effects were reverted after washout of the antagonist.
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Summary for Lay Audience
Traumatic brain injury (TBI) causes lasting changes which make the brain susceptible to
developing epilepsy. Stressful events that occur after TBI often trigger the occurrence of seizures
and increase the likelihood that the brain will become epileptic. The exact interaction between
the effects of TBI and stress that leads to epilepsy is unclear and needs investigation. It is known
that the amygdala, a small region of the brain that plays a key role in processing stress, is often
damaged due to the effects of TBI. Therefore, this phenomenon can be studied by measuring the
activity of the amygdala that has been affected by TBI and stress. We can simulate these effects
and measure the outcome using an animal model. For the experiments in this thesis, SpragueDawley rats were given a moderate TBI via a surgical process and a recording electrode was
implanted in the amygdala of each rat. The brain-injured rats were stressed for short periods of
time by applying a stressor called the tail pinch. Recordings of the amygdala during stress
revealed the occurrence of high-frequency oscillations (HFOs), which are brainwaves that are
implicated in the development of epilepsy. Furthermore, these HFOs were found to be
interacting with another simultaneously occurring brainwave called the theta oscillation, which
seemed to be acting like a pacemaker for the HFOs. This peculiarity, called phase-amplitude
coupling, may be a contributing mechanism to the interaction between TBI and stress that leads
to epilepsy.
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Chapter 1
Chapter 1: Introduction
In brief, the goal of this thesis is to study the effect of acute stress on the excitability of the
amygdala following a traumatic brain injury by measuring high-frequency oscillations. To
understand the context behind this investigation, this thesis will start broadly with the definition
of epilepsy, how traumatic brain injury leads to epilepsy, and how stress precipitates its
development. Then, it will explore the methods in which this phenomenon can be studied,
including the basics of electrophysiological extracellular recording, the definition of highfrequency oscillations, and the concept of cross-frequency coupling.

1.1 Epilepsy
Epilepsy is one of the most common chronic neurological disorders, affecting between 0.5-1% of
the Canadian population (Tellez-Zenteno et al., 2004; Reid et al, 2012). It has a substantial
impact on the quality of life of affected individuals and has an estimated cost of approximately
$13 billion each year (Begley and Durgin, 2015). Epilepsy is defined as a neurological condition
in which the brain is abnormally susceptible to generating seizures. Seizures are transient
occurrences of aberrantly excessive or synchronous neuronal activity that create abnormal
behaviours including but not limited to jerking muscle movement, cognitive deficiencies, and
loss of consciousness (Scharfman, 2007). The clinical definition of epilepsy is defined as a brain
state that generates two or more unprovoked seizures that occurs more than 24 hours apart
(Fisher et al. 2014). Unprovoked in this sense means that they were not evoked to occur by
means of stimulation and are idiopathic. The process by which a healthy brain becomes epileptic
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is complex and not fully understood. There is no ‘one cause’ that leads to epilepsy; indeed, many
different mechanisms may be involved in producing many different epileptic brains. Different
forms of epilepsy have different manifestations and implications for treatment and management.
This speaks to the significant undertaking we have in understanding the disorder and to the
humble paucity of understanding that we currently have of this condition and to the workings of
the brain.

1.1.1 History of Epilepsy
Epilepsy has been witnessed and studied for millennia and had been the subject of much
mysticism and wonder. Early shamans and healers who observed people spontaneously
convulsing thought them to be possessed by evil spirits. In fact, the word “seizure” originates
from the purported seizing of a person’s mind and body by the gods as a form of punishment for
immoral acts or simply for their wanton will. Those afflicted by epilepsy were perceived as
unholy or morally defective and were treated as lesser citizens (Magiorkinis et al, 2010).
One of the first recorded cases that referred to a biological origin to epilepsy was made by
Hippocrates in 400BC (Temkin, 1933). He described epilepsy as the result of an imbalance of
humours, a prevailing theory of physiology at the time, rather than due to godly intervention or a
failure of moral character. Moreover, he astutely linked epilepsy to a malfunction in the brain, a
monumentally innovative insight in a time when the brain was believed to be merely a large
vessel for cooling the blood, and the seat of consciousness was thought to reside in the heart
(Laskaris, 2002). He wrote that we “ought to know that from nothing else but the brain come
joys, delights, laughter and sports, and sorrows, griefs, despondency, and lamentations”, and that
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“by the same organ we become mad and delirious”, which had a prevailing impact for
understanding epilepsy and the brain in general (Hippocrates, 400 BC).
Our modern understanding of epilepsy begins in the 19th century with the seminal work of
Bouchet and Cazauvieilh (1825) examining cadavers affected by epilepsy, specifically observing
profound structural changes in the brain. Jackson (1899) provided descriptive clinical details of
seizures and suggested possible mechanisms that became foundational to the study of epilepsy.
Technological advances in the 20th century, notably the invention of the electroencephalogram
(EEG), allowed for further study of brains and seizures (Jasper et al, 1951). Parallel to these
breakthroughs, the fundamentals of nerve function were elucidated by Hodgkin and Huxley
(1952) advancing knowledge about the brain and epilepsy. Present day research in epilepsy
builds upon the technological and anatomical foundations presented by these seminal works.

1.1.2 Seizures
Seizures are sudden and transient occurrences that last from 30 seconds to minutes at a time that
are the result of uncontrolled bursts of neuronal activity in the brain. This activity has been found
to be the result of abnormal synchronized action potential firing in a group of neurons
(Bromfield et al, 2010). The excessive excitatory signalling stems from a perturbation in the
normal balance between excitation and inhibition of neuronal firing (Scharfman et al, 2007).
This imbalance can be caused by an over-excitation of excitatory neurons or by a failure of the
inhibitory interneurons that normally attenuate excessive firing. The epileptic brain is thus
characterized by networks of neurons that are configured in a hyperexcitable manner.
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The activation of these hyperexcitable networks results in seizures, which are categorized into
two main groups: generalized seizures and focal seizures (also called partial seizures). In
generalized seizures, neurons in multiple regions of the brain fire excessively together and result
in convulsions and loss of consciousness. Focal seizures occur when the abnormal firing is
localized in a unilateral region in the brain and can cause hallucinations or fugue states (Scheffer
et al., 2017). The region in which the focal seizure is localized is called the epileptic focus.
Temporal lobe epilepsy (TLE) is the most common type of epilepsy involving focal seizures
(Téllez-Zenteno and Hernández-Ronquillo, 2011).

1.2 Traumatic Brain Injury (TBI) and Post-Traumatic Epilepsy (PTE)
One of the leading causes of the development of temporal lobe epilepsy is traumatic brain injury
(TBI; Yeh et al, 2013; Xu et al., 2017). TBI refers to an external force that injures the brain and
the subsequent changes that occur. Compared to general population, individuals affected by a
TBI have on average a 3-fold higher risk of developing TLE (Martin et al., 2014). Epilepsy that
occurs following TBI is referred to as post-traumatic epilepsy (PTE) and accounts for 20% of
cases of acquired epilepsy (Agrawal et al., 2006). The exact reason for the development of PTE
remains unclear, but the link between TBI and the development of epilepsy is well documented
(Rehman et al., 2015; Chen et al., 2017). It is known that acutely, TBI causes tissue deformation
leading to damage to neurons, glia, and blood vessels which may result in a seizure immediately
following injury (Mendelow and Crawford, 1997; Laurer et al., 2000). There are many
mechanisms that could explain why this acute seizure occurs (Hunt et al., 2013). It is commonly
thought that a primary driver of acute seizures is an immediate excessive release of glutamate in
response to the injury followed by a significant increase in extracellular calcium concentration
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that causes excitotoxicity and neuronal cell death (DeLorenzo et al., 2005). However, not all
cases of TBI lead to an acute seizure, and the occurrence of an initial seizure is not predictive of
the development of PTE or its severity (Aroniadou-Anderjaska et al., 2008). Following the TBI,
there is a latent period that is seizure-free that lasts from two weeks to months or even years.
During this period, neurons and glia undergo a cascade of molecular, cellular, and
conformational changes, including inflammatory responses, perturbed cellular calcium
homeostasis, formation of scar tissue called cicatrix, and structural alterations to neural circuitry
such as axonal sprouting and neurogenesis (Mendelow and Crawford, 1997; Hunt et al., 2013).
This secondary damage is thought to lead to a disturbance in the brain’s ability to maintain the
normal balance of excitatory and inhibitory neurotransmission, and is called epileptogenesis, or
the gradual process by which a brain becomes epileptic (Herman, 2002). After this period,
seizures may occur repeatedly and these late seizures are understood to be due to a lasting
change in the brain’s structure (Hunt et al., 2013). Further investigation of the mechanisms of
epileptogenesis following TBI are required as they are poorly understood in current literature.

1.3 Stress
Stress is a complicated response that involves a cascade of hormonal and behavioural responses
that ready an organism to adapt to perceived or actual dangers (Paykel, 1979). Notably, a
heightened level of stress is a precipitating factor for seizures after TBI (Reddy and Rogawski,
2002) with stress being the most commonly reported trigger for seizures in epileptic patients
(Joëls, 2009). Numerous case studies have shown that patients comorbid with TBI and a stress
disorder have a notably high risk of developing epilepsy (Arborelius et al., 1999; Pompili et al.,
2005; Hettema et al., 2006). Specifically, war veterans with TBI and PTSD are a subpopulation
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that has one of the highest odds of developing PTE (Salazar et al., 1995). Neural processes that
generate and regulate responses to stress are poorly understood and the mechanism by which
stress exacerbates epileptogenesis in PTE is the subject of much investigation.

1.3.1 Amygdala
The amygdala is a small almond-shaped subcortical structure that resides in the temporal lobe
and exhibits increased activity in response to stress. Stress affects neuronal activity in many
brain regions, including the amygdala which is well recognized for its central role in the
expression and modulation of emotion (Davis and Shi; 1999). The amygdala is integral in
processing emotional responses and providing an affective context to sensory processes and is
thus a canonical site of study for responses to stress such as conditioned fear and anxiety (Benini
and Avoli, 2005; Aroniadou-Anderjaska et al., 2007).
The amygdala is often implicated in epilepsy as an “epileptic focus”, or a region from which
epileptic neuronal activity originates and spreads to other structures (Lv et al., 2014). Extensive
damage is present in the amygdala in a significant subpopulation of epileptic patients, especially
in those with a TBI (Aroniadou-Anderjaska et al., 2007). Epileptic patients with amygdalar
damage often report an “aura” that occurs before the onset of seizures, which are premonitory
changes in emotion or sensation that alert the patient that a seizure is about to occur such as
sudden sensations of terror and anger (van Elst et al., 2009). These clinical presentations of stress
processed by the amygdala are also supported by evidence from animal models, which has
shown that the amygdala is hyperactivated in stressed states (Roozendaal et al., 1997; Pitman et
al., 2012). Thus, the amygdala provides a site of study that facilitates the investigation of the
effects of both stress and TBI on epileptogenesis.
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1.3.2 Corticotropin-Releasing Factor (CRF)
Corticotropin-releasing factor (CRF) is a 40 amino acid neuropeptide that is implicated in the
response to stress, including in several psychiatric disorders such as anxiety, panic disorder,
PTSD, and depression (Arborelius et al. 1999; Boyer 2000). It is released ubiquitously in the
central nervous system, notably by neurons of the central amygdala. Intracerebroventricular
administration of CRF results in seizures and epileptiform activity in the amygdala in rats (Weiss
et al. 1986). Moreover, repeated bouts of CRF-induced seizures were found to make the
amygdala more and more susceptible to producing a seizure via electrical stimulation (Arborelius
et al., 1999). CRF acts with high affinity on type 1 CRF receptors (CRFR1), a G-protein-coupled
receptor, and with low affinity on type 2 CRF receptors (CRFR2), both of which are highly
expressed in the basolateral amygdala (Dedic et al., 2018). The action of CRFR1 neurons is
predominately involved in the control of anxiety-like behaviour (Merali et al., 2004). Previous
work has shown that in epileptic piriform cortex, a structure that is highly interconnected with
the amygdala, activation of CRFR1 augments principal cell excitation. This alteration in function
appears to be due to a change in the signalling pathway activated by the CRFR1 following
epileptogenesis, which occurs through attenuated expression of a regulator of G-protein
signalling protein type 2 (Narla et al., 2015). These receptors are structurally and functionally
similar to those found in the amygdala, and an analogous alteration may take place in epileptic
amygdala (Fu & Neugebauer 2008). In summary, CRFR1 activation in the amygdala is
associated with the response to stress and is implicated in epileptogenesis.
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1.4 Electrophysiology
Galvani (1791) discovered that neuronal functioning could be assessed based on its electrical
activity. By using metal, glass, or silicon electrodes to measure the transmembrane voltage
changes that occur with the flux of ions between neurons and their extracellular environment, the
workings of neurons could be measured with a high signal-to-noise ratio. This method is called
electrophysiology and has been regarded as the “gold standard” for studying neurons for the past
century (Scanziani and Häusser, 2009). Since Galvani, the experimental techniques and
equipment have been improved and refined, but the fundamentals remain the same.
The current most common method of observing large-scale neuronal signalling in humans is
through the electroencephalogram (EEG), which uses an array of macro-electrodes placed on the
scalp to pick up summed electrical signals that are conducted from the cortex and subcortical
structures through the skull and to the scalp (Varela et al., 2001; Steriade, 2006). While this
method is the least invasive type of electrophysiology, it is also less specific temporally and
spatially in assessing neuronal activity than more precise methods such as in vivo extracellular
recording.

1.4.1 In vivo Extracellular Recording
There are always trade-offs in choosing a method of recording electrical signals from the brain.
Typically, as signals get more exact temporally or spatially, they also become more invasive and
costly. This trade-off can be worth the improved signal, often justifying the more invasive in vivo
recording, or implanting electrodes surgically in live brain tissue. This is a method that can
gather information about neuronal workings at a higher signal-to-noise ratio and with more
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specificity than EEG recordings. These electrodes lie in the extracellular space between neurons
and it is thus called an extracellular recording (Heinricher, 2004).
The flow of ions that occurs during neural functioning results in an electric field that is
conducted through the extracellular space. An extracellular recording captures the voltage
changes of this electric field, and results in oscillations that exist within a frequency range called
the local field potential (LFP; Buzsaki and Draguhn, 2004). The LFP is a complex phenomenon
that gives a window into the mechanisms of neuronal communication (Engel, 2001; Canolty and
Knight, 2010). It is the summed electrical activity that is comprised of the rhythmic discharge of
groups of neurons and can influence and coordinate the timing of neuronal firing (Buzsaki and
Watson, 2012). Within the LFP, there are several discrete oscillations that are delineated into
small bands of frequency ranges. These oscillations are highly conserved in mammals, birds, and
fish and have been shown to have distinct roles in normal functioning (Buzsaki and Draguhn,
2004; Fries, 2009). For example, the theta oscillation (4 – 8 Hz) has been implicated in important
and complex brain functions such as memory consolidation and navigation in the hippocampus
and prefrontal cortex (Canolty et al., 2006; Colgin, 2013). While the exact function and
mechanism of theta and other rhythms are currently unknown, it is undeniable that these LFP
oscillations are pervasive throughout the brain and play a key role in higher-level functions.
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1.4.3 High Frequency Oscillations (HFOs)
High frequency oscillations (HFOs) are oscillations in the broadband signal that have a much
faster frequency (>120 Hz) than those that are found in the normal range of an LFP (Jacobs et al.,
2012). They are transient and local phenomena that are thought to be the manifestations of the
bursts of neuronal activity that characterizes seizures. These bursts are the result of
hypersynchronous firing of action potentials of excitatory pyramidal cells which are ubiquitous
in cortex and in limbic structures such as the hippocampus and amygdala (Bragin et al., 2004;
Haufler and Pare, 2014). HFOs occur on a much smaller spatial and temporal scale than LFP
oscillations and can be specific to 1mm3 of brain tissue and a millisecond timescale (Staba et al.,
2017). There is an abundance of evidence that supports the presence of these HFOs before,
during, and after seizures in epileptic animal models as well as in epileptic human patients
(Ponomarenko et al, 2003; Bragin et al., 2004; Jefferys et al., 2012). The presence of HFOs in a
specific area of brain tissue is considered a biomarker for epileptic tissue. Resection of brain
tissues that display HFOs in human patients has been shown to ameliorate seizure outcomes in
cases of epilepsy refractory to medication (Rosenow and Lüders, 2001). Notably, resection of
epileptic amygdala has been more successful than resections of epileptic hippocampus in
decreasing epileptic activity (Boling, 2018).
HFOs are generally categorized into two types: ripples (120 - 250Hz) and fast ripples (250 500Hz; Jiruska et al., 2017). The exact mechanism of HFO production is under investigation, but
both types are present in epileptic tissue and reflect hyper-excitable network dynamics. However,
ripples can be present during normal processes such as in REM sleep and consummatory
behaviour, while fast ripples are more often exclusive to epileptic states (Jefferys et al., 2012).
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Ripples are caused by the rhythmic and synchronous firing of action potentials in an ensemble of
pyramidal cells. However, physiological limits, such as the absolute refractory period during
repolarization after an action potential, prevent firing of individual neurons at fast ripple
frequencies (Ibarz et al., 2010). Therefore, the occurrence of fast ripples by the firing of one
synchronous group of neurons is unlikely. Indeed, fast ripples are believed to arise from
alterations in the network dynamics of these pyramidal cells (Bikson et al., 2003; Jiruska et al.,
2010). For example, loss or damage to pyramidal cells in a cluster of neurons could prevent the
normal synchronization of these cells through gap junctions, leading to two disparate
synchronously firing groups that are offset from each other that results in an oscillation at fast
ripple frequencies (Roopun et al., 2010). As well, two offset firing groups could result from a
change in the morphology of axons that normally provide an input into the cluster of pyramidal
cells due to axonal sprouting or damage (Ibarz et al., 2010). Finally, frequencies at fast ripples
could occur by the rapid firing of a group of neurons that lack the normal level of synchrony,
resulting in a chaotic firing pattern. While it is unclear which of these proposed mechanisms is
predominant in PTE, it is evident that fast ripples are a marker for a hyperexcitable epileptic
group of neurons (Thomschewski et al., 2019).

1.5 Cross-Frequency Coupling (CFC) and Phase-Amplitude Coupling (PAC)
Cross-frequency coupling (CFC) is a phenomenon that is thought to contribute to complex
functions such as memory and decision making (Canolty and Knight, 2010). CFC is the coupling
of a higher frequency signal to a lower frequency signal of a different origin. The idea is that
these two waves work together; the slower and broader low frequency wave that exists across a

12

large population of neurons coordinates the faster and more locally occurring high frequency
wave (Tort et al., 2008; Aru et al., 2015). If the two waves that are coupled together arise from
different biophysical origins, the coupling is not likely to have spurious correlations based on
volume conduction or synchronized noise (Dvorak and Fenton, 2014). Phase-amplitude coupling
(PAC) is a type of CFC in which the phase of a low frequency wave drives the amplitude of a
higher frequency wave. For example, bursts of high frequency wave activity could have a
rhythmic pattern of occurring on the troughs of a low frequency wave (Ibrahim et al., 2014).
PAC has been studied in rodents, non-human primates, and in humans and plays a key role in
integrating information within networks during complex functions such as memory encoding and
selective attention (Canolty and Knight, 2010).
Tort et al. (2010) developed a method which quantifies the intensity of PAC using a measure
called the Modulation Index (MI). This index is able to detect coupling between two frequency
ranges of interest. It measures the magnitude of nesting of the amplitude of one frequency, called
the “amplitude-modulated frequency”, within the phase of another frequency, called the “phasemodulating frequency”. The measure compares the distribution of the amplitude of the
amplitude-modulated frequency among discrete and uniform bins of the phase of the phasemodulating frequency. This distribution is compared to a null distribution using a premetric
called the Kullback-Leibler distance, which is a widely used statistical tool to calculate the
difference between two probability distributions. The null distribution used in the calculation of
the MI is flat, where amplitude is spread out perfectly evenly over each phase bin, representing
an absence of any coupling. The MI value ranges from 0 to 1, in which a value of 0 indicates that
the distribution is perfectly similar to the flat distribution, while a value of 1 indicates that the
amplitude oscillation exists only in one phase bin, both of which are physiologically unlikely
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extremes. The MI value must be interpreted against a surrogate value that is generated by
random shuffling of frequency pairings for the specific experiment in order to determine the
significance of that value.
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1.6 Rationale
TBI often leads to the development of refractory epilepsy. The severity and occurrence of
seizures in PTE is exacerbated by events of stress. The interaction between TBI and stress in
epileptogenesis is poorly understood and can be investigated using in vivo extracellular
recordings in the amygdala. This thesis investigates the generation of HFOs by CRFR1 neurons
and possible PAC of these HFOs to LFP oscillations during stress in the amygdala following
TBI.

1.6.1 Hypothesis
In an altered amygdala affected by the secondary effects of TBI, the occurrence of a stressor is
hypothesized to cause increased excitability through activation of CRFR1, resulting in the
production of pathophysiological HFOs. Furthermore, it is hypothesized that an underlying LFP
oscillation supports the generation of these HFOs through PAC.
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Chapter 2
Chapter 2: Methods
2.1 Animals
Adult male Sprague-Dawley rats weighing 150 – 180 g were used in all experiments.
They were housed individually with free access to food and water under a continuous 12/12 h
light/dark cycle. Ketamine medetomidine hydrochloride (0.1mL/100g) was given
intraperitoneally as anaesthetic. The rat is placed in an anaesthetic chamber and gas isoflurane (at
5% concentration) is administered in a stream of oxygen at 2-4L/min until the rat is recumbent
and unresponsive to stimuli. The rat is then given an injection of buprenorphine (0.05Mg/kg)
subcutaneously as a further anaesthetic and taken out of the chamber to have its site of surgery
shaved with a hair clipper. The appropriate plane of anaesthesia is verified by testing the
withdrawal reflex (toe-pinching) and palpebral reflex (eyelid closing in response to stimulus).
Breathing is constantly visually monitored. Temperature is maintained at 37°C using a heating
pad and monitored with a rectal thermometer. The front incisors of the rat are clamped onto the
bite bar of the stereotaxic apparatus, and ear bars covered with xylocaine gel (topical analgesic)
are placed in the ear canals to stabilize the head and ensure the top of the head is level. Eye
ointment (LacriLube) was applied throughout the procedure to prevent irritation and drying of
the eyes. Throughout surgery, gas isoflurane is titrated to keep the rat at the surgical plane of
anaesthesia (1.0 to 2.0% isoflurane concentration).
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2.2 Stereotaxic Surgery
The shaved surgical area is cleaned with povidone-iodine, 80% ethanol, and bacteriostat.
A vertical scalpel incision is made from between the eyes to the interaural line, about a 6 to 8mm
longitudinal cut along the midline. Blood and tissues on the skull are wiped away using cotton
swabs and gauze. The surgical site is held open using sterile tissue clamps that clip onto and peel
back the subcutaneous membrane. The fascia is scored and gently removed with a scalpel.
Bregma is located and used as the origin coordinate for the stereotaxic system.
A small hole about 1.0 mm in diameter is drilled 2.0 mm anterior to bregma and 4.8 mm
lateral to the midline and carefully cut out of the skull. The piece of the skull from the
craniotomy is kept moist in a saline solution for later reattachment. The pneumatic impactor
(Precision Science Instruments) is placed over the craniotomy site and the parameters of the
machine are set to simulate moderate TBI. The injury parameters consisted of 2.5-mm cortical
compression at a speed of 3.5 m/s for 500 ms (Dixon et al., 1991). The skull piece is then
reaffixed over the area using VetBond tissue glue. Sham animals received a craniotomy in the
same fashion but did not receive an impact to the brain. The vitals and plane of anaesthesia of the
rat are carefully monitored throughout the process.

2.2.1 Bilateral Electrode Implantation
The site of electrode implantation in the amygdala, 2.6 mm posterior to bregma and 4.8
mm lateral to the midline, is found and marked using a pencil (Paxinos and Watson, 1986). 2 mm
burr holes are made in these spots, as well as in five other spaced out spots on the skull (one in
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each quadrant separated by the coronal suture and the sagittal suture, and one below lambda).
The grounding jeweller’s screw is placed in the top-left burr hole, and the other five holes are
filled with regular jeweller’s screws. The electrodes were made of two twisted strands of 0.127
mm diameter diamel-insulated nichrome wire and were attached to male amphenol pins. The
electrode is affixed to the crossbar on the stereotax and lowered slowly into the burr hole at one
of the electrode sites until a depth of 8.0 mm (Paxinos and Watson, 1986), and then slightly
withdrawn to relieve stress in the tissue at the tip of the electrode. Dental acrylic is then used to
keep the electrode in place.
The implanted electrode and grounding wire are inserted into a plastic headplug, and then
the skull and jeweller’s screws are covered with dental acrylic, so that only the top of the
headplug is left uncovered. The headplug allows for contact with the electrodes by the recording
device during experiments while keeping them safe and out of reach at other times. The acrylic is
allowed to dry and then the remaining skin gap below the site is sutured. The rat is removed from
the ear bars and bite bar of the stereotax. Topical application of bupivacaine gel is applied on the
margins where the acrylic meets the head of the rat. The rat is given 1 mL/kg of saline
subcutaneously after surgery for hydration and allowed to regain consciousness under a heating
pad in a clean cage. The procedure lasts approximately 60 - 90 minutes.

2.2.3 Post-Operative Procedure
Rats are kept in clean recovery cages with Bed-o-Cob bedding for the first 24 hours after
surgery. Water and food pellets are readily provided. Meloxicam (1.5Mg/kg) is given
subcutaneously once a day for two days following surgery as analgesic. As well, buprenorphine
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(0.05Mg/kg) is given every 8 hours for up to two days after surgery. The rats are examined
everyday for one week post-surgery for normal grooming, behaviour, weight gain, and
adaptation to their headcap. These details are recorded on the post-op sheet. After one week, the
weight and condition of the rat is recorded once a week. If discomfort is noticed, buprenorphine
(0.05Mg/kg) is administered once every eight hours as needed to relieve pain.
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2.3 In vivo Recording Protocol
Both TBI and sham surgery rats underwent the same recording protocol at least one week after
surgery. During this protocol, a rat was transferred to a recording chamber and connected to the
head-cap of the recording system. Following 5 min of acclimatization to the chamber
environment, baseline measurement of the brain activity was taken via the implanted electrodes
for 2 min (after amplification using a Grass instruments Model 55 preamplifier; a Molecular
Devices Digidata 1550 A/D converter; sampling rate = 4 kHz). Following this 2 minute segment,
a paper clip of moderate strength was placed on the middle of the tail of the animal to act as an
acute stressor. The tail was covered with a paper towel or a clean cotton rag before the clip was
applied to prevent pain and local damage of the tissue. This stressor was applied for 2 min, and at
the end of this time, the clip was removed. The recording continued for a further 2 min in the
absence of stress. This procedure is not considered to be painful.
6-minute electrophysiological recordings were taken every two days after recovery from surgery.
These recordings consisted of 2 minutes of baseline, followed by 2 minutes of stress, then 2
minutes of post-stress. Stress was delivered by applying a tail pinch using a binder clip affixed to
the midpoint of the tail. After three weeks, rats were given CP 154526 via subcutaneous injection
(50mg/kg) before recording, to observe the effects of the CRFR1 antagonist.
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2.4 Data Analysis
Recordings were analyzed using MATLAB 2018a (MathWorks). To visualize the spectral
responses that occurred during the stressor, the raw signal was filtered using FIR filters or
convolved with complex Morlet wavelets to extract frequency-specific power and to transform
the signal into a time-frequency representation. The Morlet wavelets were constructed with
seven wavelet oscillations (Tallon-Baudry et al., 1997):

where w is the morlet wavelet, t is time, and σ describing the Gaussian shape around f0, the
central frequency, with

and the normalization factor A equal to

The recordings were also visually checked for spikes that when filtered may produce artifacts
resembling fast ripples (Bénar et al., 2010).

21

2.4.1 Filtering for LFP Oscillations and HFOs
To examine the average responses of the two groups across the entire HFO range, the recordings
were high pass filtered at 120 Hz using a FIR filter. Power spectra were then generated for the
baseline and stress response. The two spectra were then subtracted and normalized. For the five
rats analyzed in each group, sham and TBI, these subtracted and normalized spectra were then
averaged to generate an aggregate response for these two groups.

2.4.2 Wavelet Spectral Analysis
Analyses were done using MATLAB 2018a (MathWorks). For the results shown in Figures 1 –
3, the raw signal was filtered into LFP oscillations, ripple, and fast ripple ranges using band-pass
FIR filters. For Figures 4 -7, raw signals were filtered into oscillations using convolution with
complex Morlet wavelets. To extract low frequency phase, the real component of the result of
convolution of the raw signal with wavelets (centered at 1 – 21 Hz in steps of 2 Hz) was taken.
The amplitude envelope of higher frequencies was extracted by squaring the result of
convolution of the raw signal and wavelets (centered at 20 – 500 Hz in steps of 10 Hz). Peaks of
high power activity during the stress epoch of the recording within band-specific frequencies
were found. Peaks of high power were defined as areas in the spectrogram space that had
amplitudes greater than >95% of the whole 6 minute recording. One-second windows centered
on each high power peak were analyzed for their strength of phase-amplitude coupling using the
modulation index (MI; Tort et al., 2010). A window length of 1 s was chosen because this length
matched the duration of HFO bursts during stress. The HFO amplitudes within each window
were normalized and then binned into co-occurring theta phases spaced into 20° segments. The
normalized mean high frequency amplitude value at each low frequency phase bin, known as the
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pj value in the calculation of the MI (Tort et al., 2010), for each high-power window for all rats
in each drug condition were pooled. Pooling these 1 s windows found over the 2 min stress
epoch gives a more robust estimation of coupling than simply calculating the MI over a longer
time window, especially during the drug condition, in which the signal-to-noise ratio is much
lower due to reduction in occurrence and amplitude of HFO events. The pooled normalized
values were used to calculate the MI at each frequency pairing during each drug condition and
are represented in comodulograms showing preferred frequency of coupling in Figure 6.
Oscillation-triggered comodulograms (OTC) were created by summing 1s of raw recordings
centered on the high power peaks to reveal underlying rhythmic low-frequency activity (Dvorak
and Fenton, 2014; Samiee and Baillet, 2017) as shown in Figure 8. The OTC is a measure of
PAC that requires fewer assumptions on the data and reveals if there is a strong underlying slow
wave in the activity of another frequency of interest and is used here to augment the evidence
provided by the MI analysis.
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2.4.3 Modulation Index
The following steps were performed to calculate the MI value, as adapted from Tort et al. (2010).
1. First, the raw signal, xraw(t), is filtered at the 2 frequency ranges under analysis (fp and

fA). The filtered signals are denoted as xfp(t) and xfA(t).
2. The time series of the phases of xfp(t) [denoted as fp(t)] is obtained taking the real
component of the result of convolution with a 7-oscillation Morlet wavelet. The square of
the result of convolution was taken as the time series of the amplitude envelope of xfA(t)
[denoted as AfA(t)] The composite time series [fp(t),

AfA(t)] is then constructed, which

informs the amplitude of the fA oscillation at each phase of the fp rhythm.

3. The phases fp(t) are binned into eighteen 20° intervals (0° to 360°), and the mean of AfA
over each phase bin is calculated. We denote as AfAfp(j) the mean AfA value at the phase
bin j.
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4. We then apply the entropy measure H, defined by:

where N = 18 (i.e., the number of bins) and pj is given by

5. The MI is finally obtained by normalizing H by the maximum possible entropy value
(Hmax), which is obtained for the uniform distribution pj

= 1/N (and hence

Hmax = logN):

Comodulograms are then obtained by systematically matching each fp(t) to each AfA(t), creating
all possible composite pairings and then representing the MI value in a pseudocolour plot.
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2.4.4 Surrogate Analysis
Surrogate analyses were performed via shuffling the phase of one window with the amplitude of
another window (n = 10,000) in the frequency pairing of interest and then averaging the
calculated MI in each of those shuffled outcomes. Custom MATLAB scripts were written for
these analyses and are available upon request.
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Chapter 3
Chapter 3: Results
In contrast to mice, rats in this TBI model rarely develop spontaneous seizures
(Bolkvadze and Pitkänen, 2012). Nevertheless, as reported in the past (Pitkänen et al., 2009,
2014), injured rats do have epileptiform activity. We wanted to determine whether TBI rats
would respond to an acute stressor differently than sham rats and whether electrophysiological
responses from the stressor responsive nuclei, the amygdala, may be affected. The acute tail
pinch was used to deliver a stressor to rats while recording from the amygdala (Gibb et al.,
2008).

3.1 Stress in post-TBI amygdala produces increased electrographic responses,
namely HFOs
Extracellular electrophysiological recordings were taken in the amygdala in both TBI rats (n = 6)
and sham surgery rats (n = 4). As shown in Figure 1, the recording protocol for each trial was 6
minutes in length: 2 minutes of baseline activity, followed by 2 minutes under stress using an
acute tail pinch, and then 2 minutes of the response in the absence of the stressor. The tail pinch
was used because it is a simple and effective way to deliver an acute, easily terminable stressor
that is not considered to be painful. Sham and TBI rats were equally agitated by the stressor and
attempted to remove the clip from their tail. In sham surgery animals, the stressor resulted in a
mild increase in activity, likely reflecting processing by amygdala nuclei involved in stress (Fig
1A). Comparatively, in the TBI animal (Fig 1B), the same stressor resulted in a larger increase in

27

activity. HFOs were a prominent of this increase in activity during stress, as shown when the raw
signal is filtered by FIR filter into HFO ranges (>120 Hz).

Figure 1: Electrographic recordings of sham and TBI amygdala during stress. A, Sham rats
show mild increases in electrographic activity under acute stress. B, Comparatively, TBI animals
show a larger increase in activity during application of the stressor. The area delineated by the
red box is enlarged and high pass filtered at 120Hz and shown at the arrowhead. It is further
enlarged again to depict the HFOs that are present in the electrical response to the stressor.
Scales are provided to depict the magnitude of time (milliseconds) in the x-axis and of voltage
change (mV) in the y-axis.
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3.2 Theta and HFOs are phase-amplitude coupled during stress in post-TBI
amygdala
In Figure 2, 10s segments of high HFO occurrence during stress in TBI rats were visually chosen
for analysis after filtering the raw signal into HFO frequencies (>120 Hz). Then, a
comodulogram was generated for each segment (Fig 2A) by systematically analyzing the
coupling between each possible pairing between phase-modulating frequencies in the LFP [delta
(0.5 – 4 Hz), theta (4 – 8 Hz), alpha (8 – 12 Hz), beta (12 – 16 Hz), low gamma (30 – 80 Hz),
high gamma (80 – 120 Hz)] with amplitude-modulated frequencies [gamma (30 – 120Hz), ripple
(120 – 250 Hz), fast ripple (250 – 500 Hz)]. The frequency ranges here were extracted by
filtering the raw signal with bandpass FIR filters. These revealed theta as the dominant phasemodulated rhythm, and HFOs in both the ripple and fast ripple ranges as the amplitudemodulated rhythm.
The recordings shown in Figures 1 - 3 were taken at a sampling rate of 1000 Hz as part of a
preliminary exploration into this phenomenon. While the Nyquist frequency of the initial
sampling rate is 500 Hz and is theoretically able to detect frequencies up to the upper limit of fast
ripple frequencies (250 – 500 Hz), a sampling rate of at least four times the highest frequency of
interest is recommended to decrease aliasing that occurs in filtering. Thus, in further analyses
presented in Figures 4 - 7, the sampling rate was increased to 4000 Hz. This increased resolution
aided detection of fast ripples and differentiation between ripple and fast ripple activity.
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Figure 2: Comodulogram of 10s segment during stress in TBI amygdala. (A) Pseudocolour
plot of MI between low frequency phase-modulating rhythm (y-axis) and high frequency
amplitude-modulated rhythm (x-axis) during the 10s segment. Warmer colours represent higher
magnitude of coupling. Highest coupling in this example was between theta (4 - 8 Hz) and ripple
(120 - 250 Hz) range, followed by coupling between theta and fast ripple (250 – 500Hz). (B) The
10s segment of recording during stress filtered into theta (blue) and fast ripple (orange) waves
that were used to generate the MI value represented in the square of the comodulogram indicated
by the arrow. (C) Zoomed-in window of a 1s segment of B, showing that bursts of fast ripple
amplitude occur preferentially on the falling edge of the theta phase. (D) Phase-amplitude plot of
10s segment in B, which shows that HFO amplitude mildly prefers the 280 – 300° phase bin.
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3.3 CRFR1 antagonist (CP 154526) disrupts theta-HFO coupling
In order to investigate the effect of the acute stressor on CRFR1 activation, a protocol of
recording with and without CP 154526, a CRFR1 antagonist, was established, as shown in Figure
3. A recording of TBI rats with the same recording protocol was taken before administration of
the drug, then 3h after intraperitoneal injection (50 mg/kg) of the drug, then post-washout 24h
after drug administration. In these recordings shown in Figure 3 A-C, the signal was filtered into
theta (4 – 8 Hz; blue) and non-specific HFO (120 – 500 Hz; orange) ranges, chosen due to their
high level of coupling. The MI was calculated in these 10s segments during stress and averaged
per drug condition. In non-drug recordings, as expected, high amplitudes of HFOs were
demonstrably phase-locked to theta (MI = 1.82x10-2 ± 0.006). After the drug was applied, the
phase-amplitude coupling between theta and HFOs were markedly decreased (MI = 3.20x10-3 ±
1x10-3). After washout, the coupling returned (MI = 1.91x10-2 ± 8x10-3). The magnitude of
coupling measured by shuffling phases and amplitudes from all conditions was similar to and
slightly higher than the magnitude found during the drug condition (surrogate MI = 4.33x10-3 ±
1.4x10-2). Here, PAC exhibited a “fall-max” pattern during non-drug and post-washout
conditions, in which the maximum amplitude of HFOs were coupled to the falling edge of the
theta phase, which has been reported in other studies of phase-amplitude coupling (Zhang et al.,
2017).
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Figure 3: PAC in TBI rat amygdala during stress in non-drug, CRFR1 antagonist, and
washout. 10s segments recorded at 1kHz sampling rate from one rat are shown here. (A) High
amplitude HFO activity (orange) repeatedly occurs on the falling edge of the theta rhythm. (B)
This phase-amplitude coupling is disrupted after intraperitoneal injection of CP 154526, a
CRFR1 antagonist. (C) Coupling recovers after washout. (D to F) Phase-amplitude coupling
plots depict average amplitude of HFOs at theta phases binned in 20° segments during stress in
non-drug, drug, and post-washout conditions. (G) The Modulation Index (MI), a measure of the
magnitude of coupling, was averaged in the segments collected from all TBI rats during the
different drug conditions. The mean difference between non-drug and drug, and between drug
and post-washout conditions were statistically significant (ANOVA; p < 0.05). The red dotted
line denotes MI from shuffled surrogates (n = 106).
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3.4 TBI rats under stress show higher excitability than sham rats in 4kHz
amygdala recordings
Of interest was whether ripples (120 – 250 Hz) and fast ripples (250 – 500Hz) became more
prevalent as the increased occurrence of the latter wave forms is more closely associated with
epileptic activity (Jefferys et al., 2012). A new cohort of rats were operated on in the same
procedure with sham surgery (n = 5) and TBI rats (n = 5) in preparation of use with the recording
setup with an increased sampling rate of 4000Hz. Again, in sham rats the responses to this
stressor were mild (Fig. 4A) and less high frequency content was present as seen in the
spectrogram (Fig. 4E), although the rats were equally agitated and attempted to remove the clip
from their tail in response to the stressor. In Figure 4B, a typical electrical response from a TBI
rat recorded from the amygdala during a tail pinch stressor is shown. This electrophysiological
response in the TBI rats was accompanied by stage 2–3 seizures (Racine scale; mean = 2.5, 0.4
SD; n = 5; Racine et al., 1988). Sham rats did not demonstrate any visual seizure behaviors. In
Figure 5C, we show a subsample of the response in Figure 5B (150 ms). The unfiltered sample is
shown in black, while the band-passed 120 – 250 Hz is in red, and high pass filtered above 250
Hz is in blue, showing both ripples and fast ripples, respectively. In Figure 5D, we show the
averaged power spectra of the high-passed filtered recordings (>120 Hz) from five sham TBI and
five TBI rats. This was done by subtracting the power spectra of the baseline from the spectra
during stressor responses. The baseline corrected spectra were then normalized and averaged.
We found little or no increase in power at high frequencies in the sham rats, but in TBI rats, the
power increased by 2.5-fold, particularly >250 Hz (p = 0.001, Kolmogorov–Smirnov distribution
test). A spectral analysis of the entire response using a Morlet wavelet transform revealed a small
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increase in power at frequencies up to 100 Hz in the sham rats but HFOs (ripples and fast
ripples) were rare, although some were observed (Fig. 5E). This was very different in TBI rats
(Fig. 4F), where both kinds of ripples occurred during the application of the stressor. Figure 4F,
inset, shows the wavelet analysis over a 500-ms window of the spectrogram, demonstrating
occurrence of HFO bursts.
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Figure 4: Stress induces a larger electrographic response in the amygdala of TBI than in
sham rats. A, Recording of TBI rat amygdala response from a sham-operated rat showed a mild
electrographic response to a tail pinch stress, while in B, TBI-injured rats showed a large
increase in electrical activity. C, A 100-ms sample of a response where ripples (red; 120 - 250
Hz) and fast ripples (blue; 250 – 500 Hz) are clearly visible. D, Mean normalized power spectra

35

of sham (n = 5) and TBI rats (n = 5). HFOs compared to lower frequencies showed a 2.5-fold
change in power in TBI rats, but little change in sham rats. E,F, A comparison of frequency
content of sham rats’ response using Morlet wavelet analysis shows that sham rats have only
small response to the stressor, while in TBI rats, large increases in electrical activity during
stressor. The inset smaller window shows well-resolved fast ripple activity (the white * marks
approximate time from which the window was obtained; white scale bar is 100 ms).
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3.5 CRFR1 antagonism in vivo in post-TBI amygdala reduced electrographic
response and HFOs during stress in 4kHz recordings
Figure 5 shows a typical electrophysiological response from a TBI rat and its attenuation by the
CRFR1 antagonist CP 154526 (1.5h after an intraperitoneal injection of 50 mg/kg). All rats did
not exhibit seizure behaviour during the drug condition. The accompanying Morlet wavelet
analyses showed a marked attenuation of activity in both high and low frequencies 3h after the
injection, which was reversed in the recording 24h later.
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Figure 5: CRFR1 antagonist reduces HFO activity in TBI amygdala during stress. A, Tail
pinch response from a TBI rat followed by the response after the application of CP 154526, a
CRFR1 antagonist, which is followed by a recovery trace after 24 h of drug washout. Duration of
stress is indicated by the bar placed above the control response which was for 2 min. B, Morlet
spectrograms which correspond to the traces shown in A.
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3.6 CRFR1 activity mediates fast ripples and PAC between theta and fast
ripples during stressor in post-TBI amygdala in 4kHz recordings
We next examined whether the high-frequency activity was cross-frequency coupled to any
particular frequencies. Figure 6 shows a summary of the PAC (Tort et al., 2010) between lowfrequency activity (binned on x-axis) versus high frequencies (binned on the y-axis) in the
signals before, during, and after CRFR1 antagonist treatment. The averaged MI values from all
five rats are shown in this analysis and are color-coded as a heat map. The non-drug responses
showed that again in theta (4 – 8 Hz), there was a high magnitude of PAC in both the ripple and
fast ripple bands. This was particularly prominent between the fast ripple whose MIs were the
largest (MI = 2.05x10-3 vs surrogate MI = 5.47x10-5). In the CP 154526-treated rats, the coupling
between theta and high-frequency bands was again attenuated. These MIs calculated in the
presence of antagonist were below chance, as compared to surrogate analyses of shuffling (MI =
1.28x10-3 vs surrogate MI = 4.11x10-3). After recovery, the coupling between theta and the ripple
and fast ripple bands were again present (MI = 1.56x10-3 vs surrogate MI = 2.77x10-5). These
recordings did not exhibit the same fall-max pattern in coupling.
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Figure 6: Comodulograms depict theta-HFO PAC in non-drug and washout conditions, but
not after administration of CRFR1 antagonist. A, upper traces: Examples of fast ripple
activity and theta in non-drug, CP 154526, and after 24h drug washout from TBI rats under stress
filtered into (4 – 8 Hz, blue) and fast ripples (250 – 500 Hz, orange) bands. B, Comparison of
MIs between low-frequency phase on x-axis and higher frequency amplitude between 250 and
500 Hz on y-axis. Fast ripples are significantly and highly coupled over the frequency bins
corresponding to theta rhythm. Ripple activity is also coupled to a lesser extent in the same
range. This relationship is abolished by CRFR1 antagonism. Very low-frequency activity (2–4
Hz) is apparently coupled over a wide range of high-frequency activity. The MI values
corresponding to this coupling during antagonist are below chance. After 24h, the PAC returned.
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3.7 Oscillation-triggered comodulogram shows underlying theta activity in
fast ripple ranges
Finally, to confirm the PAC analysis, an oscillation-triggered comodulogram was also calculated
(Dvorak and Fenton, 2014). This calculation was done for the pooled data before, during, and
after CRFR1 antagonism. The crests of fast ripple activity aligned at a slow oscillation of 0.2 s
between crests, or an underlying wave that resonated at 5 Hz (theta). This analysis supports the
observations using the MI described by Tort et al. (2010) by providing another measure of
coupling that uses the raw data and does not rely on assumptions of linearity or harmonic
artifacts that can occur after filtering.
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Figure 7: OTC shows coupling between theta and fast ripples that is attenuated by CRFR1
antagonist. Another method of showing CFC from data recorded during a stressor in TBI rats.
The oscillation-triggered comodulogram (OTC) shows coupling between fast ripples and an
underlying 5 Hz theta oscillation without antagonist and after washout of antagonist. During
antagonist, destructive interference of the pooled LFPs shows no significant coupling.
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Chapter 4
4. Discussion
4.1 Stress Exacerbates Post-Traumatic Epileptogenesis
TBI is a major risk factor in the development of epilepsy (Xu et al., 2017). PTSD and TBI are
often comorbid as brain injuries are often associated with traumatic experiences (Ohry et al.,
1996; Hickling et al., 1998; Levin et al., 2001; Greenspan et al., 2006; Gaylord et al., 2008; Hoge
et al., 2008; Bryant, 2011). To date, a few mechanisms have been proposed to account for the
high association of PTSD and the development of epilepsy such as up-regulated glutamate
neurotransmission, axonal damage, and compromised interneuronal circuits (Guerriero et al.,
2015). CRF has been implicated in several brain disorders such as anxiety, stress, depression,
and neuropathic pain. Clinical studies have shown that increased concentrations of CRF in the
CSF are associated with PTSD (Post et al., 1982) and several studies have found altered
hypothalamic pituitary adrenal (HPA) axis and CRF function in PTSD (Mason et al., 1986;
Smith et al., 1989; Pitman and Orr, 1990; Yehuda et al., 1993). Consistent with these reports,
studies in humans showed a chronic increase in CRF release following stress exposure (Dallman
and Jones, 1973). In TBI rats, CRF exhibited excitatory effects in the PCtx, a region that has
strong interconnections with the amygdala. Therefore, these changes in CRF activity have a wide
impact that either originate in the PCtx or involve changes that associate other limbic regions to
produce the electrophysiological responses we observed in the amygdala.
Importantly, the results indicate that pathologic mechanisms that accompany brain injury make
the brain susceptible to stressor-induced increases in the excitability of the amygdala. In
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particular, the phase coupling between pHFOs and LFP oscillations seem important as this
coupling may aid in the spread of the high-frequency activity contributing to epileptogenesis.
Indeed, it has been noted in previous studies that HFOs have a surprising ability to spread and
exhibit high coherence across much larger volumes than one might expect (Haufler and Pare,
2014). These findings also provide insight into why those who have suffered TBI and PTSD
have a 3-fold increase in the incidence to develop epilepsy, which is often pharmacoresistant
(Hitiris et al., 2007).

4.2 High-Frequency Oscillations are Increased and Phase-Amplitude Coupled
during Stress
Recently, HFOs have been the subject of great interest in epileptogenesis. Here, both ripples
(120 – 250 Hz) and fast ripples (250 - 500 Hz) have been investigated. Ripples are generally
thought to be physiologic, whereas fast ripples are generally considered to be pathologic,
supporting the generation of epileptic seizures (Bragin et al., 1999; Jefferys et al., 2012). This
view is by no means settled and other phenomena may also need to be considered as contributing
to the occurrence of seizures. These include whether they are bursting, like observed here, or
steady state HFOs, phase locked to a behavioural or electrical event, and their location (Jefferys
et al., 2012). Also, it has been reported that ripples are associated with epileptic behaviour in
animal models (Shiri et al., 2016) as well as in humans (Weiss et al., 2016). The other issue is
whether pHFOs are an epiphenomena or causative of the epileptic state. Evidence that the latter
may be true comes from work showing that during the transition period from the latent to the
chronic phase in the pilocarpine model of mesial temporal lobe epilepsy, there is an increased
incidence of HFO activity in the EC and CA3 region of the hippocampus (Salami et al., 2014)
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and the blocking of their occurrence with the anti-epileptic drug levetiracetam impeded the
generation of seizures. Here, we have recorded HFOs from the amygdala, a region of the brain
that readily supports the development of seizures (McIntyre et al., 2002). Previously, HFOs have
been isolated in the amygdala and associated limbic regions (DEn, central amygdala, EC, and
PCtx; Ponomarenko et al., 2003; Haufler and Pare, 2014; Salami et al., 2014). In general, these
studies have found that HFOs occur regionally in a highly synchronous manner so that HFOs
occurring in one region are highly correlated with occurrences in other regions. In fact, it was
noted that an apparently unusual property of HFOs relative to LFP oscillations was their high
coherence (Haufler and Pare, 2014). LFP coherence usually decreases with distance, and this
reduction is quite steep for their fast components such as gamma (Steriade et al., 1996; Collins et
al., 2001). In addition, the main difference between what was observed in past reports and the
findings here is that the fast ripples were highly phasic locked to theta (4 – 8 Hz). A recent study
has shown that high-power low-frequency oscillations coupled to HFOs could be readily
identified in a brain region of patients with pharmacoresistant epilepsy and when this region was
subsequently removed, better clinical outcomes of seizures were observed (Cotic et al., 2016).
This supports the idea that the cross-frequency coupling of HFOs to LFP oscillations seems to be
highly epileptogenic.

4.3 Altered Interneurons May Lead to Epileptiform Activity
While it clear that stress generates HFOs, the mechanism by which this occurs is unclear. It
seems likely that activation of CRFR1 is influencing the activity of the local circuit neurons in
the amygdala to produce these network effects, as evidenced by the decrease in HFO amplitude
and occurrence following administration of the CRFR1 antagonist. Changes in network activity
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often implicates changes in interneuron function, and in some cases, CRF application converted
slow-firing interneurons to fast-firing ones, and conversely converted fast-firing interneurons
into slow-firing ones, disrupting normal networking (Narla et al., 2015). Moreover, interneurons
may become functionally silent after an insult. Evidence for this interpretation comes from a
study where the perforant path model of temporal lobe epilepsy was used. Sloviter (1987)
described disruption of functional inhibition in the presence of viable interneurons and
functionally active GABAA receptors in the dentate gyrus and CA1 areas of hippocampus
(Sloviter, 1987, 1991). Similar observations were also observed by two other studies showing no
loss of GABAergic interneurons (Bekenstein and Lothman, 1993; Lothman et al., 1996) but a
reduction in inhibitory activity. Similar observations were reported in the tetanus toxin model of
epilepsy where evidence for the existence of functionally dormant interneurons was shown
(Jefferys and Traub, 1998). Further studies will be required to provide insight into how CRF
affects the rewiring of amygdala neurons following TBI.

4.4 Limitations
One of the main limitations of animal models of PTE is that only a relatively small proportion of
animals develop PTE. Non-traumatic animal models of epilepsy have a relatively high incidence
of post- intervention epilepsy with reliable induction of multiple seizures per day. By contrast,
experimental PTE is associated with a much lower seizure frequency and duration. In one study
of PTE using continuous intracranial monitoring for 11 months after TBI, the average rate of
seizures was one every 1–2 weeks (Kharatishvili et al., 2006). In another study of PTE using the
lateral fluid percussion injury model, 94% of experimental animals showed
electroencephalogram (EEG) evidence of non-convulsive seizures, but these generally lasted less
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than ten seconds (Campbell et al., 2014). Unlike many other experimental models of epilepsy,
experimental PTE often leads to generalized epilepsy that is relatively easy to evaluate using
video monitoring to establish frequency and severity of seizure activity (Racine, 1972).

4.5 CRFR1 Antagonists as an Anti-Epileptic Drug
Our current findings suggest that CRFR1 antagonists may have a clinical importance as
antiepileptic drugs. CRFR1 antagonists have long been under investigation for treating stress
related disorders such as anxiety and depression, although the results have not been promising
(Zorrilla and Koob, 2004; Valdez, 2009). No clinical study has investigated or argued for the use
of CRFR1 antagonists to attenuate epileptogenesis following TBI. Also, it has been observed that
exogenously applied CRF induced excitotoxicity of interneurons (Aldenhoff et al., 1983; Bishop
and King, 1992), which suggests that CRFR1 antagonists may be effective in providing
neuroprotection in the hippocampus following seizure (Maecker et al., 1997) and after cerebral
ischemia (Lyons et al., 1991).

4.7 Conclusion
In summary, our findings provide a mechanism by which individuals affected by TBI develop
stress-associated PTE. CRFR1 activation in the amygdala is associated with changes in
excitability in the amygdala following brain injury. In particular, the generation of fast ripples
during the response and their PAC to LFP oscillations could be particularly epileptogenic. Our
observations indicate that the epileptic state was accompanied by greater susceptibility to
stressor-induced excitability in a brain region that supports seizures. These findings suggest that
the underlying brain pathology may be an important determinant in the exacerbation of epilepsy

47

in response to heightened anxiety. In effect, the neuronal network alterations support
hyperexcitability and seizure onset, and the epileptic state makes the brain more susceptible to an
otherwise physiological response to stress.
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